PharmaResources (Shanghai) Co. Ltd. A Total Liabilities

Latest as of March 2026: CN¥285.89 Million CNY ≈ $41.83 Million USD

PharmaResources (Shanghai) Co. Ltd. A total liabilities. Based on the latest financial reports, PharmaResources (Shanghai) Co. Ltd. A (301230) has total liabilities worth CN¥285.89 Million CNY (≈ $41.83 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of PharmaResources (Shanghai) Co. Ltd. A to evaluate the company's liquid asset resilience ratio.

Total Liabilities of PharmaResources (Shanghai) Co. Ltd. A (2020–2025)

Total liabilities of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025. This chart illustrates how PharmaResources (Shanghai) Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data.

PharmaResources (Shanghai) Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of PharmaResources (Shanghai) Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Aeroflex Industries Limited NSE:AEROFLEX	India	Rs1.09 Billion
Six Flags Entertainment Corporation NYSE:FUN	USA	$7.32 Billion
Caisse Régionale de Crédit Agricole Mutuel de Paris et d-Ile-de-France PA:CAF	France	€70.19 Billion
One United Properties SA RO:ONE	Romania	RON3.08 Billion
Dexterra Group Inc TO:DXT	Canada	CA$467.63 Million
LianChuang Electronic Technology Co Ltd SHE:002036	China	CN¥15.41 Billion
Avino Silver & Gold Mines Ltd TO:ASM	Canada	CA$53.59 Million

Liability Composition Analysis (2020–2025)

This chart breaks down PharmaResources (Shanghai) Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 301230 asset base.

Liquidity & Leverage Metrics

PharmaResources (Shanghai) Co. Ltd. A Total Liabilities Ratios Explained

PharmaResources (Shanghai) Co. Ltd. A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PharmaResources (Shanghai) Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)

The table below shows the annual total liabilities of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥309.87 Million ≈ $45.34 Million	+9.21%
2024-12-31	CN¥283.73 Million ≈ $41.52 Million	-23.24%
2023-12-31	CN¥369.62 Million ≈ $54.09 Million	+96.21%
2022-12-31	CN¥188.38 Million ≈ $27.57 Million	-10.03%
2021-12-31	CN¥209.37 Million ≈ $30.64 Million	+88.93%
2020-12-31	CN¥110.81 Million ≈ $16.22 Million	--

About PharmaResources (Shanghai) Co. Ltd. A

SHE:301230 China Biotechnology

Market Cap

$811.00 Million

CN¥5.54 Billion CNY

Market Cap Rank

#9545 Global

#2376 in China

Share Price

CN¥30.63

Change (1 day)

+7.51%

52-Week Range

CN¥22.55 - CN¥65.76

All Time High

CN¥65.76